Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|9|1|2-8
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.9, Iss.1, 2008-02, pp. : 2-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy
Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. :
Access to resources
Recommend
ADAM10 as a Therapeutic Target for Cancer and Inflammation
Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. :
Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. :